The present results suggest that addressing the trafficking and oxidative stress problem through manipulation of PARP-1 and related pathways may be a useful approach for restoring homeostasis and should be investigated further in the context of CF therapeutics. This evidence concerns the gene PARP1 and cystic fibrosis.